Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 1.02
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.
Data is available to registered users only
Buy
Sell